Catch up on Jim Cramer's thinking over the past week about the resilience of the market and misses from some initial public offerings.
TheStreet's Jim Cramer tells people his elective hand surgery went well and the prognosis is good.
Accept the risk you're taking on and, above all, be a grown-up about it.
TheStreet's Jim Cramer says that everyone wants to play the high multiple, high flying names, but what Cramer likes is low risk, high reward situations.
TheStreet's Jim Cramer tells investors to 'buy them all' since it has been confirmed that Lorillard has been talking with Reynolds meaning tobacco consolidation will happen.
Cheap money and greed from the Allergan bidder's side are strong incentives.
TheStreet's Jim Cramer and Stephanie Link discuss Alcoa's good quarter and guidance in aerosopace and auto.
TheStreet's Jim Cramer asks investors if Allergan has the ability to fight off Valeant.
Here are several themes that are still working -- and now you can get in at a bargain.
Some large account could have liquidated positions yesterday.